acquired
Stage
1
Investors
About
Oxular develops drug-device combination treatments for retinal diseases, using sustained-release formulations for targeted delivery to ocular tissues.
Explore Oxular's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.